Reducing uncertainty about flavivirus infections

Lancet Infect Dis. 2017 Jan;17(1):13-15. doi: 10.1016/S1473-3099(16)30524-2.

Authors

Adam Kucharski¹, Steven Riley²

Affiliations

¹ Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK. Electronic address: adam.kucharski@lshtm.ac.uk.
² MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.

PMID: 27998552
DOI: 10.1016/S1473-3099(16)30524-2

No abstract available

MeSH terms

Antibodies, Viral / blood*
Cross Reactions
Flavivirus / immunology*
Flavivirus Infections / diagnosis*
Flavivirus Infections / epidemiology
Flavivirus Infections / virology
Humans
Risk
Serogroup
Uncertainty
Zika Virus / immunology
Zika Virus Infection / diagnosis
Zika Virus Infection / epidemiology
Zika Virus Infection / virology

Substances

Antibodies, Viral

Grants and funding